Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bramlage

Showing results (131-140 of 429) with videos related to

Pageof 43
Sort By:
Clinical Drug Investigation|October 5, 2007
BP goal achievement in patients with uncontrolled hypertension : results of the treat-to-target post-marketing survey with irbesartanJoachim Schrader, Peter Bramlage, Stephan Lüders, et al.
European Journal of Pediatrics|February 26, 2017
Validation of the custo screen pediatric blood pressure monitor according to the European Society of Hypertension International Protocol revision 2010Beate Beime, Cornelia Deutsch, Ralf Krüger, et al.
Journal of Cardiothoracic Surgery|August 6, 2020
Long-term outcomes of concomitant tricuspid valve repair in patients undergoing mitral valve surgeryAyse Cetinkaya, Natalia Ganchewa, Stefan Hein, et al.
Herz|October 7, 2020
Reduced rate of admissions for acute coronary syndromes during the COVID-19 pandemic: an observational analysis from a tertiary hospital in GermanyGaetano Vacanti, Peter Bramlage, Gerhard Schymik, et al.
BMC Endocrine Disorders|October 9, 2015
Treatment intensification using long-acting insulin -predictors of future basal insulin supported oral therapy in the DIVE registryThomas Danne, Tobias Bluhmki, Jochen Seufert, et al.
Blood Pressure Monitoring|March 20, 2021
Validation of the blood pressure measurement device Beurer BM 28 according to the European Society of Hypertension International Protocol revision 2010Cornelia Deutsch, Carsten Bramlage, Beate Botta, et al.
Future Cardiology|October 7, 2009
Albuminuria: pathophysiology, epidemiology and clinical relevance of an emerging marker for cardiovascular diseaseMartin Thoenes, Peter Bramlage, Bobby V Khan, et al.
Cardiovascular Diabetology|December 11, 2012
Achievement of recommended glucose and blood pressure targets in patients with type 2 diabetes and hypertension in clinical practice - study rationale and protocol of DIALOGUEAnselm K Gitt, Roland E Schmieder, Eva Duetting, et al.
Journal of Thoracic Disease|August 18, 2020
Gender differences in aortic valve replacement: is surgical aortic valve replacement riskier and transcatheter aortic valve replacement safer in women than in men?Maria Giulia Caponcello, Lucia M Banderas, Carmen Ferrero, et al.
BMC Endocrine Disorders|May 3, 2015
Achievement of individualized treatment targets in patients with comorbid type-2 diabetes and hypertension: 6 months results of the DIALOGUE registryRoland E Schmieder, Anselm K Gitt, Cornelia Koch, et al.
Pageof 43

Showing results (131-140 of 429) with videos related to

Sort By:
Pageof 43
Clinical Drug Investigation|October 5, 2007
BP goal achievement in patients with uncontrolled hypertension : results of the treat-to-target post-marketing survey with irbesartanJoachim Schrader, Peter Bramlage, Stephan Lüders, et al.
European Journal of Pediatrics|February 26, 2017
Validation of the custo screen pediatric blood pressure monitor according to the European Society of Hypertension International Protocol revision 2010Beate Beime, Cornelia Deutsch, Ralf Krüger, et al.
Journal of Cardiothoracic Surgery|August 6, 2020
Long-term outcomes of concomitant tricuspid valve repair in patients undergoing mitral valve surgeryAyse Cetinkaya, Natalia Ganchewa, Stefan Hein, et al.
Herz|October 7, 2020
Reduced rate of admissions for acute coronary syndromes during the COVID-19 pandemic: an observational analysis from a tertiary hospital in GermanyGaetano Vacanti, Peter Bramlage, Gerhard Schymik, et al.
BMC Endocrine Disorders|October 9, 2015
Treatment intensification using long-acting insulin -predictors of future basal insulin supported oral therapy in the DIVE registryThomas Danne, Tobias Bluhmki, Jochen Seufert, et al.
Blood Pressure Monitoring|March 20, 2021
Validation of the blood pressure measurement device Beurer BM 28 according to the European Society of Hypertension International Protocol revision 2010Cornelia Deutsch, Carsten Bramlage, Beate Botta, et al.
Future Cardiology|October 7, 2009
Albuminuria: pathophysiology, epidemiology and clinical relevance of an emerging marker for cardiovascular diseaseMartin Thoenes, Peter Bramlage, Bobby V Khan, et al.
Cardiovascular Diabetology|December 11, 2012
Achievement of recommended glucose and blood pressure targets in patients with type 2 diabetes and hypertension in clinical practice - study rationale and protocol of DIALOGUEAnselm K Gitt, Roland E Schmieder, Eva Duetting, et al.
Journal of Thoracic Disease|August 18, 2020
Gender differences in aortic valve replacement: is surgical aortic valve replacement riskier and transcatheter aortic valve replacement safer in women than in men?Maria Giulia Caponcello, Lucia M Banderas, Carmen Ferrero, et al.
BMC Endocrine Disorders|May 3, 2015
Achievement of individualized treatment targets in patients with comorbid type-2 diabetes and hypertension: 6 months results of the DIALOGUE registryRoland E Schmieder, Anselm K Gitt, Cornelia Koch, et al.
Pageof 43